Academic Journal

Prognostic impact of H3K27me3 expression on locoregional progression after chemoradiotherapy in esophageal squamous cell carcinoma

التفاصيل البيبلوغرافية
العنوان: Prognostic impact of H3K27me3 expression on locoregional progression after chemoradiotherapy in esophageal squamous cell carcinoma
المؤلفون: Liao Yi-Ji, Rao Hui-Lan, Li Bin-Kui, Liu Meng-Zhong, He Li-Ru, Guan Xin-Yuan, Zeng Yi-Xin, Xie Dan
المصدر: BMC Cancer, Vol 9, Iss 1, p 461 (2009)
بيانات النشر: BMC, 2009.
سنة النشر: 2009
المجموعة: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
الوصف: Abstract Background Trimethylation of lysine 27 on histone H3 (H3K27me3) by enhancer of zeste homolog 2 (EZH2) is an epigenetic mark that mediates gene silencing. EZH2 is overexpressed and correlates with poor prognosis in many cancers. However, the clinical implication of H3K27me3 in human malignancies has not been well established. We wished to ascertain whether a correlation exists between the expression of H3K27me3 and clinical outcome in a group of patients with esophageal squamous cell carcinoma (ESCC) treated with definitive chemoradiotherapy (CRT). Methods The method of immunohistochemistry (IHC) was utilized to examine the protein expression of H3K27me3 in 98 pretreatment biopsy specimens of ESCC and in 30 samples of normal esophageal mucosa. The clinical/prognostic significance of H3K27me3 expression was statistically analyzed. Results The expression frequency and expression levels of H3K27me3 were significantly higher in ESCCs than in normal tissues. There was a positive correlation between H3K27me3 expression and WHO grade (P = 0.016), tumor size (P = 0.019), T status (P = 0.024), locoregional progression (P = 0.009) and EZH2 expression (P = 0.036). High H3K27me3 expression was associated with poor locoregional progression-free survival (LPFS) (P = 0.010) in ESCC. Further analysis demonstrated that H3K27me3 could stratify patient outcome in T2-3 (P = 0.048), N0 (P = 0.005) and M0 (P = 0.018) stages as well as in CRT effective group (P = 0.022). Conclusions Our data suggests that H3K27me3 expression examined by IHC might be useful for stratifying LPFS for different subsets of ESCC patients treated with definitive CRT.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1471-2407
Relation: http://www.biomedcentral.com/1471-2407/9/461; https://doaj.org/toc/1471-2407
DOI: 10.1186/1471-2407-9-461
URL الوصول: https://doaj.org/article/611cfe4f623c4c62b5ee8f909a2b47f8
رقم الانضمام: edsdoj.611cfe4f623c4c62b5ee8f909a2b47f8
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:14712407
DOI:10.1186/1471-2407-9-461